Fabienne Dobbels
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fabienne Dobbels has a total of 210 co-authors. Here are the top co-authors by number of shared publications:
- Anouk Delameillieure
Dept of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, University of Leuven, Leuven, Belgium
6 shared publications Nathalie Duerinckx
Academic Center for Nursing and Midwifery, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Heart transplant program and Competence Center of Nursing, University Hospitals of Leuven, Leuven, Belgium
6 shared publicationsSabina De Geest
Academic Centre for Nursing and Midwifery, Department of Public Health and Primary Care, KU Leuven - University of Leuven, Belgium; Institute of Nursing Science, Department Public Health, University of Basel, Switzerland
6 shared publications- Sabina De Geest
Nursing Science, Department of Public Health, University of Basel, Basel, Switzerland
6 shared publications - Janette Ribaut
Institute of Nursing Science, Department Public Health, Faculty of Medicine, University of Basel, Basel, Switzerland
4 shared publications Jeanette Boyd
European Lung Foundation, Sheffield, UK
4 shared publications
Latest Publications
- 23 September 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (12) , e121-e147
Engagement of Social Support Systems in Patients Being Considered for and Following Advanced Heart and Lung Surgical Therapies: An ISHLT Expert Consensus Statement
- 23 September 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (12) , e121-e147
Engagement of Social Support Systems in Patients Being Considered for and Following Advanced Heart and Lung Surgical Therapies: An ISHLT Expert Consensus Statement
- Open Access
- 24 April 2026
- Published by Elsevier in SSRN Electronic Journal
Task-shifting to advanced practice nurses in Flanders: a cross-sectional survey of physician’s knowledge and attitudes
Background: Healthcare systems face increasing pressures that drive interest in task-shifting to advanced practice nurses (APNs), a strategy supported by substantial evidence and reforms in many countries. Belgium only recently formalized role expansion of APNs through new legislation that authorizes defined diagnostic, treatment, prescribing, and coordination activities within collaborative agreements.Objective: This study investigates physicians’ attitudes toward task-shifting from physicians to APNs, identifies perceived barriers to such task-shifting, and maps both current and potential areas in which task-shifting may occur. Additionally, the study explores physicians’ views on the added value of collaborating with APNs.Design: Online cross-sectional survey.Setting and participants: 634 hospital-based physicians.Methods: Quantitative and qualitative data were collected using a self-developed questionnaire in REDCap between May and June 2025. The survey comprised six sections addressing respondents’ background, collaboration with APNs, knowledge of and attitudes toward the recent legislation, and views on potential task-shifting across eight regulated activities. Analyses were conducted in IBM SPSS Statistics (version 30). Descriptive statistics included frequencies and percentages for categorical and Likert‑scale items. Inferential analyses comprised Mann–Whitney U tests and Spearman’s rank correlation to explore associations between variables. Open‑ended responses were analysed using thematic analysis following Braun and Clarke’s six‑phase framework.Results: Among physicians, 18.8% reported being well informed about the new legislation, and 79.9% anticipated impacts on patient care. Overall, 56.9% rated the legislation positively, with less favourable views in dermatology and anesthesiology. Attitudes were more positive among physicians in university hospitals (U = 23,471, p < 0.001, r = 0.21) and those collaborating with an APN (U = 24,172.50, p < 0.001, r = 0.27). The activities most frequently delegated to APNs are patient anamnesis and the coordination of referrals to physicians within the same discipline and to other healthcare providers. In future, more than half of physicians (between 54.5% and 77.2%, depending on discipline) indicated a willingness to delegate six of the eight surveyed activities. Most frequently reported barriers related to perceptions of physician‑exclusive tasks, whereas financial concerns and doubts about APN added value were least reported. Physicians perceived APNs as contributing most to improved care quality, addressing unmet needs, and enhancing efficiency.Conclusions: Most physicians find the new task‑shifting legislation positive and believe APNs can enhance care quality, address unmet needs, and improve efficiency. However, several barriers remain, highlighting the need for clearer information, defined roles, and robust frameworks for training, liability, and financial arrangements.Registration: Not registered.
- 24 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessTask-shifting to advanced practice nurses in Flanders: a cross-sectional survey of physician’s knowledge and attitudes
Background: Healthcare systems face increasing pressures that drive interest in task-shifting to advanced practice nurses (APNs), a strategy supported by substantial evidence and reforms in many countries. Belgium only recently formalized role expansion of APNs through new legislation that authorizes defined diagnostic, treatment, prescribing, and coordination activities within collaborative agreements.Objective: This study investigates physicians’ attitudes toward task-shifting from physicians to APNs, identifies perceived barriers to such task-shifting, and maps both current and potential areas in which task-shifting may occur. Additionally, the study explores physicians’ views on the added value of collaborating with APNs.Design: Online cross-sectional survey.Setting and participants: 634 hospital-based physicians.Methods: Quantitative and qualitative data were collected using a self-developed questionnaire in REDCap between May and June 2025. The survey comprised six sections addressing respondents’ background, collaboration with APNs, knowledge of and attitudes toward the recent legislation, and views on potential task-shifting across eight regulated activities. Analyses were conducted in IBM SPSS Statistics (version 30). Descriptive statistics included frequencies and percentages for categorical and Likert‑scale items. Inferential analyses comprised Mann–Whitney U tests and Spearman’s rank correlation to explore associations between variables. Open‑ended responses were analysed using thematic analysis following Braun and Clarke’s six‑phase framework.Results: Among physicians, 18.8% reported being well informed about the new legislation, and 79.9% anticipated impacts on patient care. Overall, 56.9% rated the legislation positively, with less favourable views in dermatology and anesthesiology. Attitudes were more positive among physicians in university hospitals (U = 23,471, p < 0.001, r = 0.21) and those collaborating with an APN (U = 24,172.50, p < 0.001, r = 0.27). The activities most frequently delegated to APNs are patient anamnesis and the coordination of referrals to physicians within the same discipline and to other healthcare providers. In future, more than half of physicians (between 54.5% and 77.2%, depending on discipline) indicated a willingness to delegate six of the eight surveyed activities. Most frequently reported barriers related to perceptions of physician‑exclusive tasks, whereas financial concerns and doubts about APN added value were least reported. Physicians perceived APNs as contributing most to improved care quality, addressing unmet needs, and enhancing efficiency.Conclusions: Most physicians find the new task‑shifting legislation positive and believe APNs can enhance care quality, address unmet needs, and improve efficiency. However, several barriers remain, highlighting the need for clearer information, defined roles, and robust frameworks for training, liability, and financial arrangements.Registration: Not registered.
- Open Access
- 30 January 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (4)
‘Good Health’ and care needs in IPF/PPF: The COCOS-IPF Patient-led European Focus Groups
Idiopathic pulmonary fibrosis (IPF) and other progressive forms of pulmonary fibrosis (PPF) place a heavy burden on patients’ lives. While research on clinical aspects of IPF and PPF progresses, evidence on patients’ subjective experiences is still emerging. This qualitative study investigated how patients with IPF/PPF and caregivers define “good health”, key health outcomes of the care they receive, and unmet care needs. This work is part of the COCOS-IPF project, which aims to develop a Core Outcome Set for IPF and PPF. Methods: Together with the European Lung Foundation and the European Pulmonary Fibrosis Federation, focus groups were conducted by trained patient representatives, supported by allied health professionals, across five European countries. Discussions followed a semi-structured topic guide. An inductive thematic analysis was performed, following Braun and Clarke's framework for extraction of qualitative data, with findings refined through consensus meetings. Results: Our analyses revealed 10 major themes reflecting participants’ perspectives on health, reflecting four broader areas: social connectedness, adaptive strategies and activity, physical and emotional wellbeing, and overarching perceptions of quality of life and normality. One additional major theme summarises participants’ unfulfilled care needs, including access to clear information, holistic and person-centred care, and attention to psychological and social needs. Conclusion: Patients and caregivers define good health in a multidimensional way, linking physical, emotional, and social aspects. Including these perspectives in developing the IPF/PPF Core Outcome Set could better align care with patients’ real-life needs and priorities.
- 30 January 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (4)
Open Access‘Good Health’ and care needs in IPF/PPF: The COCOS-IPF Patient-led European Focus Groups
Idiopathic pulmonary fibrosis (IPF) and other progressive forms of pulmonary fibrosis (PPF) place a heavy burden on patients’ lives. While research on clinical aspects of IPF and PPF progresses, evidence on patients’ subjective experiences is still emerging. This qualitative study investigated how patients with IPF/PPF and caregivers define “good health”, key health outcomes of the care they receive, and unmet care needs. This work is part of the COCOS-IPF project, which aims to develop a Core Outcome Set for IPF and PPF. Methods: Together with the European Lung Foundation and the European Pulmonary Fibrosis Federation, focus groups were conducted by trained patient representatives, supported by allied health professionals, across five European countries. Discussions followed a semi-structured topic guide. An inductive thematic analysis was performed, following Braun and Clarke's framework for extraction of qualitative data, with findings refined through consensus meetings. Results: Our analyses revealed 10 major themes reflecting participants’ perspectives on health, reflecting four broader areas: social connectedness, adaptive strategies and activity, physical and emotional wellbeing, and overarching perceptions of quality of life and normality. One additional major theme summarises participants’ unfulfilled care needs, including access to clear information, holistic and person-centred care, and attention to psychological and social needs. Conclusion: Patients and caregivers define good health in a multidimensional way, linking physical, emotional, and social aspects. Including these perspectives in developing the IPF/PPF Core Outcome Set could better align care with patients’ real-life needs and priorities.
- Open Access
- 29 September 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (2)
The COCOS-IPF core outcome set for idiopathic pulmonary fibrosis/progressive pulmonary fibrosis care: a mixed-method multi-perspective approach
Background: It is unclear which outcomes are essential for the care of individuals with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis (IPF/PPF). We aimed to develop a core outcome set (COS) together with patients with IPF/PPF for standard care across Europe. Methods: A modified three-round Delphi study in five languages involved patients, caregivers, pulmonologists, nurses and other healthcare professionals. The initial survey consisted of 56 outcomes potentially relevant for IPF/PFF care that were identified through a scoping review, a survey with healthcare professionals and patient-led focus groups with patients and caregivers. The importance of each outcome for IPF/PPF care was scored on a 9-point Likert scale. After each round, outcomes were removed if not deemed critically important by all stakeholder groups, using predefined criteria. Afterwards, a multi-stakeholder consensus workshop was held to endorse the included outcomes and discuss and vote on those without consensus. Results: The three rounds involved 110, 78 and 66 participants from 14 European countries (one third being patients and caregivers). 14 stakeholders contributed to the consensus workshop. The final COS consists of 17 outcomes: acute exacerbation, breathlessness, complications and side-effects of the treatment, cough, exercise capacity, lung function, nutritional status, physical activity, activities of daily living, being knowledgeable about the disease, capability to do activities you enjoy, coping with the disease, feelings of anxiety, life satisfaction, loss of independence, satisfaction with care and treatment adherence. Conclusions: This COS is recommended for use in clinical IPF/PPF care, but will also guide future intervention research.
- 29 September 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (2)
Open AccessThe COCOS-IPF core outcome set for idiopathic pulmonary fibrosis/progressive pulmonary fibrosis care: a mixed-method multi-perspective approach
Background: It is unclear which outcomes are essential for the care of individuals with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis (IPF/PPF). We aimed to develop a core outcome set (COS) together with patients with IPF/PPF for standard care across Europe. Methods: A modified three-round Delphi study in five languages involved patients, caregivers, pulmonologists, nurses and other healthcare professionals. The initial survey consisted of 56 outcomes potentially relevant for IPF/PFF care that were identified through a scoping review, a survey with healthcare professionals and patient-led focus groups with patients and caregivers. The importance of each outcome for IPF/PPF care was scored on a 9-point Likert scale. After each round, outcomes were removed if not deemed critically important by all stakeholder groups, using predefined criteria. Afterwards, a multi-stakeholder consensus workshop was held to endorse the included outcomes and discuss and vote on those without consensus. Results: The three rounds involved 110, 78 and 66 participants from 14 European countries (one third being patients and caregivers). 14 stakeholders contributed to the consensus workshop. The final COS consists of 17 outcomes: acute exacerbation, breathlessness, complications and side-effects of the treatment, cough, exercise capacity, lung function, nutritional status, physical activity, activities of daily living, being knowledgeable about the disease, capability to do activities you enjoy, coping with the disease, feelings of anxiety, life satisfaction, loss of independence, satisfaction with care and treatment adherence. Conclusions: This COS is recommended for use in clinical IPF/PPF care, but will also guide future intervention research.
- Open Access
- 28 February 2025
- Published by Springer Nature in Respiratory Research
- Vol. 26 (1) , 1-11
Person-centred health outcomes in the routine care for people with progressive pulmonary fibrosis: the COCOS-IPF project’s European survey on healthcare professionals’ views and practices
Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are interstitial lung diseases (ILD) that carry a high burden and mortality. IPF/PPF experts and patients call for standardized care, outcome harmonization and holistic management in these complex and devastating diseases, with a focus on person-centeredness. In this cross-sectional international survey study, we aimed to gather information on the person-centred health outcomes European healthcare professionals (HCPs) already use or deem important for use in routine care for IPF/PPF. This work is part of the COCOS-IPF project on developing a Core Outcome Set (COS) for and with patients with IPF/PPF. With the input of IPF/PPF experts, psychologists and patients, we developed an online survey for European multidisciplinary HCPs with IPF/PPF expertise. The survey was programmed in QualtricsXM, piloted and distributed via the networks of the COCOS-IPF consortium. We used content analysis to create an overall list of outcome domains mentioned in the survey, classified these according to the COMET (Core Outcome Measures in Effectiveness Trials) taxonomy and calculated the frequency of all outcomes mentioned. A total of 149 experts, mainly pulmonologists (n = 120, 81%) working in ILD expert centres, from 31 European countries participated. Of the 40 different outcome domains mentioned, the majority referred to `physiological/clinical` (n = 773, 81%) and `life impact` (n = 138, 14%) outcome domains. Of these, `lung function’ (n = 280, 29%), ‘exercise capacity’ (n = 123, 13%) and `quality of life` (n = 103, 11%) were reported as most frequently used person-centred health outcomes. Survey respondents deemed the same three outcome domains the most important for use in the routine clinical IPF/PPF care, supplemented by chest symptoms. Pulmonologists reported mainly about routine use of `lung function` (n = 252, 26%), while allied HCPs put more focus on outcomes related to physical condition and whole body status. HCPs have identified 40 different outcomes domains in a European multidisciplinary survey on person-centred health outcomes in IPF/PPF. Lung function, exercise capacity, quality of life and chest symptoms were rated as the most relevant health outcomes to be assessed routinely in clinical care. These insights can help to support the development of a COS for IPF/PPF clinical care.
- 28 February 2025
- Published by Springer Nature in Respiratory Research
- Vol. 26 (1) , 1-11
Open AccessPerson-centred health outcomes in the routine care for people with progressive pulmonary fibrosis: the COCOS-IPF project’s European survey on healthcare professionals’ views and practices
Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are interstitial lung diseases (ILD) that carry a high burden and mortality. IPF/PPF experts and patients call for standardized care, outcome harmonization and holistic management in these complex and devastating diseases, with a focus on person-centeredness. In this cross-sectional international survey study, we aimed to gather information on the person-centred health outcomes European healthcare professionals (HCPs) already use or deem important for use in routine care for IPF/PPF. This work is part of the COCOS-IPF project on developing a Core Outcome Set (COS) for and with patients with IPF/PPF. With the input of IPF/PPF experts, psychologists and patients, we developed an online survey for European multidisciplinary HCPs with IPF/PPF expertise. The survey was programmed in QualtricsXM, piloted and distributed via the networks of the COCOS-IPF consortium. We used content analysis to create an overall list of outcome domains mentioned in the survey, classified these according to the COMET (Core Outcome Measures in Effectiveness Trials) taxonomy and calculated the frequency of all outcomes mentioned. A total of 149 experts, mainly pulmonologists (n = 120, 81%) working in ILD expert centres, from 31 European countries participated. Of the 40 different outcome domains mentioned, the majority referred to `physiological/clinical` (n = 773, 81%) and `life impact` (n = 138, 14%) outcome domains. Of these, `lung function’ (n = 280, 29%), ‘exercise capacity’ (n = 123, 13%) and `quality of life` (n = 103, 11%) were reported as most frequently used person-centred health outcomes. Survey respondents deemed the same three outcome domains the most important for use in the routine clinical IPF/PPF care, supplemented by chest symptoms. Pulmonologists reported mainly about routine use of `lung function` (n = 252, 26%), while allied HCPs put more focus on outcomes related to physical condition and whole body status. HCPs have identified 40 different outcomes domains in a European multidisciplinary survey on person-centred health outcomes in IPF/PPF. Lung function, exercise capacity, quality of life and chest symptoms were rated as the most relevant health outcomes to be assessed routinely in clinical care. These insights can help to support the development of a COS for IPF/PPF clinical care.
- Open Access
- 22 January 2025
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 34 (175) , 240133
Identifying outcome domains to establish a core outcome set for progressive pulmonary fibrosis: a scoping review
Introduction: People with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (PPF) have a high symptom burden and a poor health-related quality of life (HRQoL). Despite efforts to offer specialised treatment, clinical care for these patients remains suboptimal and several nonmedical needs remain unaddressed. Developing a core outcome set (COS) can help to identify a minimum set of agreed-upon outcomes that should be measured and acted-upon in clinical care.Aim: As a first step towards developing a COS for IPF/PPF, we aimed to identify outcome domains investigated in IPF/PPF research.Methods: Conducted within the COCOS-IPF (Co-designing a Core Outcome Set for and with patients with IPF) project, this scoping review follows Joanna Briggs Institute methodology and PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines to search PubMed, Embase and Web of Science for quantitative, qualitative and mixed-methods papers. We extracted each paper's outcomes verbatim and classified them using the COMET (Core Outcome Measures in Effectiveness Trials) taxonomy. Then, the research team structured outcomes or concepts with similar meanings inductively into outcome domains.Results: We included 428 papers, extracting 1685 outcomes. Most outcomes (n=1340) were identified in quantitative sources, which we could classify in 64 outcome domains, with the main domains being “all-cause survival” (n=237), “lung function” (n=164) and “exercise capacity” (n=99). Qualitative sources identified 51 outcome domains, with the most frequent being “capability to do activities you enjoy” (n=31), “anxiety, worry and fear” (n=26) and “dealing with disease progression” (n=25).Conclusions: The identified outcomes, spanning diverse domains, highlight the complexity of patient experiences and can form the basis to develop a COS for IPF/PPF clinical care, as well as future research.
- 22 January 2025
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 34 (175) , 240133
Open AccessIdentifying outcome domains to establish a core outcome set for progressive pulmonary fibrosis: a scoping review
Introduction: People with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (PPF) have a high symptom burden and a poor health-related quality of life (HRQoL). Despite efforts to offer specialised treatment, clinical care for these patients remains suboptimal and several nonmedical needs remain unaddressed. Developing a core outcome set (COS) can help to identify a minimum set of agreed-upon outcomes that should be measured and acted-upon in clinical care.Aim: As a first step towards developing a COS for IPF/PPF, we aimed to identify outcome domains investigated in IPF/PPF research.Methods: Conducted within the COCOS-IPF (Co-designing a Core Outcome Set for and with patients with IPF) project, this scoping review follows Joanna Briggs Institute methodology and PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines to search PubMed, Embase and Web of Science for quantitative, qualitative and mixed-methods papers. We extracted each paper's outcomes verbatim and classified them using the COMET (Core Outcome Measures in Effectiveness Trials) taxonomy. Then, the research team structured outcomes or concepts with similar meanings inductively into outcome domains.Results: We included 428 papers, extracting 1685 outcomes. Most outcomes (n=1340) were identified in quantitative sources, which we could classify in 64 outcome domains, with the main domains being “all-cause survival” (n=237), “lung function” (n=164) and “exercise capacity” (n=99). Qualitative sources identified 51 outcome domains, with the most frequent being “capability to do activities you enjoy” (n=31), “anxiety, worry and fear” (n=26) and “dealing with disease progression” (n=25).Conclusions: The identified outcomes, spanning diverse domains, highlight the complexity of patient experiences and can form the basis to develop a COS for IPF/PPF clinical care, as well as future research.
- Open Access
- 15 January 2024
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 12 (1) , e48625
Developing a Comprehensive List of Criteria to Evaluate the Characteristics and Quality of eHealth Smartphone Apps: Systematic Review
Background: The field of eHealth is growing rapidly and chaotically. Health care professionals need guidance on reviewing and assessing health-related smartphone apps to propose appropriate ones to their patients. However, to date, no framework or evaluation tool fulfills this purpose. Objective: Before developing a tool to help health care professionals assess and recommend apps to their patients, we aimed to create an overview of published criteria to describe and evaluate health apps. Methods: We conducted a systematic review to identify existing criteria for eHealth smartphone app evaluation. Relevant databases and trial registers were queried for articles. Articles were included that (1) described tools, guidelines, dimensions, or criteria to evaluate apps, (2) were available in full text, and (3) were written in English, French, German, Italian, Portuguese, or Spanish. We proposed a conceptual framework for app evaluation based on the dimensions reported in the selected articles. This was revised iteratively in discussion rounds with international stakeholders. The conceptual framework was used to synthesize the reported evaluation criteria. The list of criteria was discussed and refined by the research team. Results: Screening of 1258 articles yielded 128 (10.17%) that met the inclusion criteria. Of these 128 articles, 30 (23.4%) reported the use of self-developed criteria and described their development processes incompletely. Although 43 evaluation instruments were used only once, 6 were used in multiple studies. Most articles (83/128, 64.8%) did not report following theoretical guidelines; those that did noted 37 theoretical frameworks. On the basis of the selected articles, we proposed a conceptual framework to explore 6 app evaluation dimensions: context, stakeholder involvement, features and requirements, development processes, implementation, and evaluation. After standardizing the definitions, we identified 205 distinct criteria. Through consensus, the research team relabeled 12 of these and added 11 more—mainly related to ethical, legal, and social aspects—resulting in 216 evaluation criteria. No criteria had to be moved between dimensions. Conclusions: This study provides a comprehensive overview of criteria currently used in clinical practice to describe and evaluate apps. This is necessary as no reviewed criteria sets were inclusive, and none included consistent definitions and terminology. Although the resulting overview is impractical for use in clinical practice in its current form, it confirms the need to craft it into a purpose-built, theory-driven tool. Therefore, in a subsequent step, based on our current criteria set, we plan to construct an app evaluation tool with 2 parts: a short section (including 1-3 questions/dimension) to quickly disqualify clearly unsuitable apps and a longer one to investigate more likely candidates in closer detail. We will use a Delphi consensus-building process and develop a user manual to prepare for this undertaking. Trial Registration: PROSPERO International Prospective Register of Systematic Reviews CRD42021227064; https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021227064
- 15 January 2024
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 12 (1) , e48625
Open AccessDeveloping a Comprehensive List of Criteria to Evaluate the Characteristics and Quality of eHealth Smartphone Apps: Systematic Review
Background: The field of eHealth is growing rapidly and chaotically. Health care professionals need guidance on reviewing and assessing health-related smartphone apps to propose appropriate ones to their patients. However, to date, no framework or evaluation tool fulfills this purpose. Objective: Before developing a tool to help health care professionals assess and recommend apps to their patients, we aimed to create an overview of published criteria to describe and evaluate health apps. Methods: We conducted a systematic review to identify existing criteria for eHealth smartphone app evaluation. Relevant databases and trial registers were queried for articles. Articles were included that (1) described tools, guidelines, dimensions, or criteria to evaluate apps, (2) were available in full text, and (3) were written in English, French, German, Italian, Portuguese, or Spanish. We proposed a conceptual framework for app evaluation based on the dimensions reported in the selected articles. This was revised iteratively in discussion rounds with international stakeholders. The conceptual framework was used to synthesize the reported evaluation criteria. The list of criteria was discussed and refined by the research team. Results: Screening of 1258 articles yielded 128 (10.17%) that met the inclusion criteria. Of these 128 articles, 30 (23.4%) reported the use of self-developed criteria and described their development processes incompletely. Although 43 evaluation instruments were used only once, 6 were used in multiple studies. Most articles (83/128, 64.8%) did not report following theoretical guidelines; those that did noted 37 theoretical frameworks. On the basis of the selected articles, we proposed a conceptual framework to explore 6 app evaluation dimensions: context, stakeholder involvement, features and requirements, development processes, implementation, and evaluation. After standardizing the definitions, we identified 205 distinct criteria. Through consensus, the research team relabeled 12 of these and added 11 more—mainly related to ethical, legal, and social aspects—resulting in 216 evaluation criteria. No criteria had to be moved between dimensions. Conclusions: This study provides a comprehensive overview of criteria currently used in clinical practice to describe and evaluate apps. This is necessary as no reviewed criteria sets were inclusive, and none included consistent definitions and terminology. Although the resulting overview is impractical for use in clinical practice in its current form, it confirms the need to craft it into a purpose-built, theory-driven tool. Therefore, in a subsequent step, based on our current criteria set, we plan to construct an app evaluation tool with 2 parts: a short section (including 1-3 questions/dimension) to quickly disqualify clearly unsuitable apps and a longer one to investigate more likely candidates in closer detail. We will use a Delphi consensus-building process and develop a user manual to prepare for this undertaking. Trial Registration: PROSPERO International Prospective Register of Systematic Reviews CRD42021227064; https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021227064
- 27 November 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (1) , e14663
Medication adherence in pediatric kidney transplantation: How to build a bridge over troubled water
Adhering to the immunosuppressive regimen remains one of the biggest challenges for children and adolescents after kidney transplantation. The first paper on nonadherence, co‐authored by Dr. Fine, appeared in Pubmed over 45 years ago. Since then, many clinicians and researchers tried to better understand nonadherence and are looking for effective ways to support young people in implementing the complex medication regimen in their daily lives. As a tribute to Dr. Fine, we conducted a comprehensive review providing an overview of adherence‐enhancing interventions in the field of pediatric kidney transplantation, thereby focusing on strategies that not only are effective but can also be embedded in daily clinical practice successfully and sustainably. This overview is preceded by a discussion about how to find out who is in need of supportive interventions. We will also argue that interventions should already start before pediatric kidney transplantation and discuss how to decide whether or not a young patient with nonadherence‐induced graft loss should undergo retransplantation. We hope this comprehensive overview will rekindle the hope that we can finally turn the tide and beat one of pediatric kidney transplantation's main enemies.
- 27 November 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (1) , e14663
Medication adherence in pediatric kidney transplantation: How to build a bridge over troubled water
Adhering to the immunosuppressive regimen remains one of the biggest challenges for children and adolescents after kidney transplantation. The first paper on nonadherence, co‐authored by Dr. Fine, appeared in Pubmed over 45 years ago. Since then, many clinicians and researchers tried to better understand nonadherence and are looking for effective ways to support young people in implementing the complex medication regimen in their daily lives. As a tribute to Dr. Fine, we conducted a comprehensive review providing an overview of adherence‐enhancing interventions in the field of pediatric kidney transplantation, thereby focusing on strategies that not only are effective but can also be embedded in daily clinical practice successfully and sustainably. This overview is preceded by a discussion about how to find out who is in need of supportive interventions. We will also argue that interventions should already start before pediatric kidney transplantation and discuss how to decide whether or not a young patient with nonadherence‐induced graft loss should undergo retransplantation. We hope this comprehensive overview will rekindle the hope that we can finally turn the tide and beat one of pediatric kidney transplantation's main enemies.
- Open Access
- 10 July 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (4) , e20220372
Cultural adaptation and validation of the Brazilian Portuguese version of the PROactive Physical Activity in COPD–clinical visit instrument for individuals with COPD
Objective: To adapt the PROactive Physical Activity in COPD-clinical visit (C-PPAC) instrument to the cultural setting in Brazil and to determine the criterion validity, test-retest reliability agreement, and internal consistency of this version. Methods: A protocol for cultural adaptation and validation was provided by the authors of the original instrument and, together with another guideline, was applied in a Portuguese-language version developed by a partner research group from Portugal. The adapted Brazilian Portuguese version was then cross-sectionally administered twice within a seven-day interval to 30 individuals with COPD (57% were men; mean age was 69 ± 6 years; and mean FEV1 was 53 ± 18% of predicted) to evaluate internal consistency and test-retest reliability. Participants also completed the International Physical Activity Questionnaire (IPAQ), the modified Medical Research Council scale, the COPD Assessment Test, and Saint George's Respiratory Questionnaire to evaluate criterion validity. Results: The C-PPAC instrument showed good internal consistency and excellent test-retest reliability:
- 10 July 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (4) , e20220372
Open AccessCultural adaptation and validation of the Brazilian Portuguese version of the PROactive Physical Activity in COPD–clinical visit instrument for individuals with COPD
Objective: To adapt the PROactive Physical Activity in COPD-clinical visit (C-PPAC) instrument to the cultural setting in Brazil and to determine the criterion validity, test-retest reliability agreement, and internal consistency of this version. Methods: A protocol for cultural adaptation and validation was provided by the authors of the original instrument and, together with another guideline, was applied in a Portuguese-language version developed by a partner research group from Portugal. The adapted Brazilian Portuguese version was then cross-sectionally administered twice within a seven-day interval to 30 individuals with COPD (57% were men; mean age was 69 ± 6 years; and mean FEV1 was 53 ± 18% of predicted) to evaluate internal consistency and test-retest reliability. Participants also completed the International Physical Activity Questionnaire (IPAQ), the modified Medical Research Council scale, the COPD Assessment Test, and Saint George's Respiratory Questionnaire to evaluate criterion validity. Results: The C-PPAC instrument showed good internal consistency and excellent test-retest reliability: